UXN Co., Ltd.
Develops a continuous glucose monitoring system using an enzyme-free nanoporous platinum sensor.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2012 and listed on KONEX in 2019, UXN is a medical device company specializing in continuous glucose monitoring systems (CGMS). Based on its enzyme-free glucose sensor technology using nanoporous platinum, it is developing a CGMS under the brand AGMS(TM). In GLP-certified animal testing the sensor achieved a MARD of 7% with 100% of readings in the A+B zone of the Error Grid Analysis, and in an exploratory clinical trial with 30 healthy subjects conducted with Korea University Guro Hospital, sensor error was at or below a MARD of 10%.
Products & technology
- AGMS (enzyme-free CGMS)Enzyme-free continuous glucose monitoring using nanoporous platinum
R&D and key agreements
Source: DART corporate disclosureAGMS · 혈당 관리 · 동물시험(GLP) 및 탐색임상 · Animal testing achieved MARD 7% with 100% in Error Grid A+B zone; clinical trial in 30 healthy subjects showed MARD of 10% or below
Companies in the same categoryMedical Devices
Founded 2009, listed on KOSDAQ in 2019, JETEMA develops hyaluronic acid fillers, botulinum toxin biopharmaceuticals, and lifting threads.
Founded in 2000 and KOSDAQ-listed in 2013, i-SENS makes blood glucose monitors and point-of-care testing devices.
Founded in 2010 and KOSDAQ-listed in 2018, Sejong Medical manufactures laparoscopic surgical instruments.
Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.
Founded in 2015 and listed on KOSDAQ in 2022, Noul develops the on-device AI diagnostic platform miLab™ for blood and cancer testing.
KOSDAQ-listed manufacturer of diagnostic X-ray imaging systems and core components such as generators and tubes.
KOSDAQ-listed molecular genetic diagnostics company providing NGS-based non-invasive prenatal testing (NIPT) under the MomGuard brand.
Founded in 2000 and KOSDAQ-listed in 2013, Corentec makes artificial joints; hip and knee implants exceed 85% of revenue.
Established in 2012 and listed on KOSDAQ in 2018, Osteonic manufactures implants for the CMF, Trauma, Sports Medicine, and Spine categories.
Founded 2010, listed on KOSDAQ in 2021, Genesystem develops molecular diagnostic systems, biochips, test kits, and reaction reagents.
Founded in 1961 and KOSPI-listed in 1976, SBSUNGBO makes and sells crop protection agents (fungicides, insecticides, herbicides).
Founded in 2000 and KOSDAQ-listed in 2010, Seegene develops syndromic multiplex PCR molecular diagnostic reagents.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition